Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.79 CAD | 0.00% | +8.32% | +12.91% |
Jun. 05 | Green Thumb Reportedly Explores Merger with Boston Beer | CI |
Jun. 05 | Boston Beer's Stock Decline Presents 'More Balanced Risk/Reward,' Morgan Stanley Says | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company has a poor ESG score according to Refinitiv, which ranks companies by sector.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 54.27 times its estimated earnings per share for the ongoing year.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+12.91% | 2.89B | D+ | ||
-12.41% | 1.29B | - | ||
+53.49% | 520M | - | ||
-9.09% | 424M | - | ||
+62.91% | 200M | - | ||
-5.99% | 90.98M | - | - | |
-23.58% | 79.73M | - | ||
+25.00% | 57.52M | - | C | |
+24.72% | 50.1M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- GTII Stock
- Ratings Green Thumb Industries Inc.